FACTORS INFLUENCING THE INCIDENCE AND COURSE OF OTITIS MEDIA IN SCARLET FEVER
Authors: Conrad Wesselhoeft
Journal: Annals of Internal Medicine (1939)

Article1 March 1939FACTORS INFLUENCING THE INCIDENCE AND COURSE OF OTITIS MEDIA IN SCARLET FEVERCONRAD WESSELHOEFT, M.D., F.A.C.P.CONRAD WESSELHOEFT, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-12-9-1473 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptOtitis media suppurativa is the most important complication in scarlet fever. Its importance is due to its frequency, to the possibility of permanent deafness, and to its relation to mastoiditis, sinus thrombosis, septicemia, petrositis, and meningitis.At the outset, we must distinguish between the manifestations of the toxin, which consist of fever, vomiting, the enanthem and the rash, and those manifestations of the pus-forming properties of hemolytic streptococci, which may also give rise to fever. A middle ear abscess is one of several possible pyogenic complications in the course of the disease. Nor does this abscess materially differ in its...References1. GUNNGRIFFITH WF: Bacteriological and clinical study of 100 cases of scarlet fever, Jr. Hyg., 1928-1929, xxviii, 258. Google Scholar2. VALENTINE E: Bacteriologic study of middle ear infections, Jr. Infect. Dis., 1924, xxxv, 204. Google Scholar3. SEIFERTH LB: Eine Studie über die Scharlach-Otitis und Labyrinthitis und deren endokranielle Folgeerkrankungen, Beitr. z. Anat. etc. Ohres, Nase u. Halses, 1932, xxix, 212. Google Scholar4. LICHTENSTEIN A: Studies in scarlet fever, Acta Paediat., 1931, x, 563. Google Scholar5. MARSIGLI> : Foreign letters, Jr. Am. Med. Assoc., 1932, xcviii, 1672. Google Scholar6. ABRAMSFRIEDMAN JIS: The problem of otitis media and mastoiditis in scarlet fever, New England Jr. Med., 1933, ccix, 494. CrossrefGoogle Scholar7. LEFLER AB: Scarlet fever otitis, Ann. Otol., Rhin. and Laryng., 1927, xxxvi, 496. Google Scholar8. HOLMGREN G: Ueber Otitis Media perforativa bei Scarlatina, Arch. f. Ohrenheilk., 1912-1913, xc, 73, 78. Google Scholar9. WEAVER GH: Scarlet fever, Abt's Pediat., 1925, vi, 334. Google Scholar10. RADE F: Ueber die Mittelohreiterung bei Scharlach, Folia Oto-Laryngologica, 1933, xxiv, 129. Google Scholar11. GOLDINBERG M: Zur Klinik der Scharlachotitis, Monatschr. f. Ohrenheilk., 1929, lxiii, 1169. Google Scholar12. HEIBERG P: Tausend Fälle von Scharlachfieber im Blegdamshospital behandelt, Ztschr. f. Hyg. u. Infektionskr., 1910, lxv, 240, 246. Google Scholar13. CAIGER FF: A note on the infectivity of rhinorrhoea and otorrhea arising in connection with scarlet fever, Met. Asylums Board Report, Med. Supplement, 1904, 313. Google Scholar14. LICHTENSTEIN A(a) : Studies in scarlet fever. IX. A note on the effect of individual isolation on the course of scarlet fever, Acta Paediat., 1931, xii, 2. (b) ibid. VII, Act Paediat., 1931, x, 572. (c) 563. Google Scholar15. KAISER AD: The relation of tonsils and adenoids to infections in children. Based on a control study of 4400 children over a ten-year period, Am. Jr. Dis. Child., 1931, xli, 580. Google Scholar16. BRADFORD WL: Tonsillectomy, its effect on the incidence, severity, and complications of scarlet fever, etc., Am. Jr. Dis. Child., 1932, xliv, 279. CrossrefGoogle Scholar17. HOFMANN L: Tonsillektomie und Scharlach, Monatschr. f. Ohrenheilk., Lar. u. Rhin., 1931, 147. Google Scholar18. NORDWALL U: Scarlet fever and diphtheria in tonsillectomized children, Act. Paediat., 1934, xv, 346. Google Scholar19. KOPETZKY SJ: Acute and chronic otitis media, sinus thrombosis and petrosal pyramid suppuration, Arch. Otolaryng., 1934, xx, 399. Google Scholar20. WILLIAMS HJ: A review of the aural and orbital complications of scarlet fever at the Philadelphia Hospital for Contagious Diseases from 1922 to 1934, Ann. Otol., Rhin., and Laryng., 1935, xliv, 110-113. CrossrefGoogle Scholar21. GOWEN FV: The incidence of otitis in 15,000 acute exanthemata, etc., Laryngoscope, 1926, xxxvi, 800. Google Scholar22. SUTLIFFPLACESEEGOL WDEHSH: Cod liver oil concentrate (concentrated vitamins A and D): Ineffectiveness of large doses in the prophylaxis of otitis media in scarlet fever, Jr. Am. Med. Assoc., 1933, c, 725. CrossrefGoogle Scholar23. CLAUSEN SW: Exploitation of vitamin A, N. Y. State Jr. Med., 1934, xxxiv, 154. Google Scholar24. PETERSHAVARD BARV: Chemotherapy of streptococcal infections with p-Benzylamino-Benzene-Sulphonamide, Lancet, 1937, i, 1273. CrossrefGoogle Scholar25. STIMSON PM: Individual isolation, Jr. Pediat., 1938, xii, 313. CrossrefGoogle Scholar26. DICKDICK GFGH: Therapeutic results with concentrated scarlet fever antitoxin, Jr. Am. Med. Assoc., 1925, lxxxiv, 804. Google Scholar27. GORDON JE: Treatment of scarlet fever with streptococcus antitoxin, Jr. Am. Med. Assoc., 1927, lxxxviii, 383. Google Scholar28. PRINZING F: Bemerkungen über Komplikationen und Nach-krankheiten des Scharlachs bei Serotherapie, Therap. Monatschr., 1928, xxxii, 17. Google Scholar29. TOOMEYDOLCH JAEG: Scarlet fever. VI. The use of antitoxins, Am. Jr. Dis. Child., 1928, xxxvi, 1176. Google Scholar30. CRAIG JC: Treatment and prophylaxis of scarlet fever with specific antitoxin serum, Lancet, 1928, ii, 1123. CrossrefGoogle Scholar31. PLACE EH: Prevention and special treatment of scarlet fever, Jr. Med. Soc. New Jersey, 1929, xxvi, 103. Google Scholar32. HAUF M: Beitrag zur Frage der Serumwirkung auf die Erscheinungen des zweiten Krankseins bei Scharlach, Arch. f. Kinderheilk., 1933, xcviii, 243. Google Scholar33. STEVENSONVELDEEMITCHELL FEMVAG: Therapeutic values of antitoxin, Ohio State Med. Jr., 1933, xxix, 423. Google Scholar34. LUCCHESIBOWMAN PFJE: Antitoxin versus no antitoxin in scarlet fever, Jr. Am. Med. Assoc., 1934, ciii, 1050. Google Scholar35. HOYNELEVINSONTHALHIMER ALSOW: Convalescent scarlet fever serum: its prophylactic and therapeutic value; review of 2,875 cases, Jr. Am. Med. Assoc., 1935, cv, 786. Google Scholar36. DOOLITTLE SE: Scarlet fever streptococcus antitoxin, Northwest Med., 1927, 26-28. Google Scholar37. SCOTT JA: Serum treatment of scarlet fever, Lancet, 1928, 124. CrossrefGoogle Scholar38. WINKEL E: Serotherapy, München, med. Wchnschr., 1932, lxxix, 707. Google Scholar39. HUNT LW: The treatment of scarlet fever with antitoxin, Jr. Am. Med. Assoc., 1933, ci, 1446. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Boston, Massachusetts*Presented at the New York meeting of the American College of Physicians, April 6, 1938. From the Department of Pediatrics, Harvard Medical School, and the Haynes Memorial, Massachusetts Memorial Hospitals. A synopsis of twelve unpublished articles dealing with this subject, based on a study of 10,000 cases of scarlet fever at the Haynes Memorial in conjunction with material gleaned from the literature. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAcademic Homeopaths ReinventedRubella (German Measles)Scarlet Fever and Related Streptococcal InfectionsScharlachThe Treatment of Diphtheria and Scarlet FeverDifferential Diagnosis of Common Infectious Diseases 1 March 1939Volume 12, Issue 9Page: 1473-1485KeywordsAbscessesFeversOtitis mediaPediatricsRashesScarlet feverSepsisThrombosisToxinsVomiting ePublished: 1 December 2008 Issue Published: 1 March 1939 PDF downloadLoading ...